Keytruda Ready to Help More People

Guest Blog by: Elvin Montanez, Pharm.D. Even more cancer patients might soon be benefiting from the cancer medication that helped former President Jimmy Carter. Keytruda (pembrolizumab) first started saving lives back in 2011 when a human trial led to an expedited process with the Food and Drug Administration (FDA). By 2014, this medication was approved…

An Inside Job

Immunotherapy as a cancer treatment, which is sometimes called biologic therapy, relies on the body’s immune defenses to stop cancer cell growth and spread, as well as uses elements of the immune system to destroy cancerous cells. Last year, as I explained in the blog, Lung Cancer: Immunotherapy Treatment Option, immunotherapy presents the possibility of…

Understanding Immuno-Oncology

The field of immuno-oncology combines an understanding of how the body’s own defenses (e.g., the immune system) can be harnessed in the fight against cancer. Cancer cells, although different than the body’s healthy cells, find ways to disguise themselves so that the immune system doesn’t recognize them as non-self and target them for destruction. Immuno-oncology…

Lung Cancer: Immunotherapy Treatment Option

Thanks to anti-smoking campaigns and plummeting smoking rates over the past 20 years, the number of people diagnosed with lung cancer has declined significantly in that same time period. Even so, lung cancer stubbornly remains the second most common cancer in both men and women and accounts for nearly one in every eight new cancers,…